- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1041
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Therapeutic drug monitoring of oral targeted antineoplastic drugs ; day:9 ; month:11 ; year:2020 ; pages:1-24
European journal of clinical pharmacology ; (9.11.2020), 1-24
- Urheber
-
McLaughlin, Anna Margarete
Groenland, Stefanie L.
Scherf-Clavel, Oliver
Dyk, Madelé van
Huisinga, Wilhelm
Michelet, Robin
Jaehde, Ulrich
Steeghs, Neeltje
Huitema, Alwin D.R
Kloft, Charlotte
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00228-020-03014-8
- URN
-
urn:nbn:de:101:1-2021012517085228280015
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- McLaughlin, Anna Margarete
- Groenland, Stefanie L.
- Scherf-Clavel, Oliver
- Dyk, Madelé van
- Huisinga, Wilhelm
- Michelet, Robin
- Jaehde, Ulrich
- Steeghs, Neeltje
- Huitema, Alwin D.R
- Kloft, Charlotte
- SpringerLink (Online service)
Ähnliche Objekte (12)
Improvement of oral antineoplastic therapy by means of pharmacometric approaches & therapeutic drug monitoring
Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review
Developing a nationwide infrastructure for therapeutic drug monitoring of targeted oral anticancer drugs: the ON-TARGET study protocol
Targeted drug delivery
Beyond Nanoparticle‐Based Intracellular Drug Delivery: Cytosol/Organelle‐Targeted Drug Release and Therapeutic Synergism
Optimization of beta-lactam dosing through targeted therapeutic drug monitoring
Riboflavin-Targeted Drug Delivery
Relationship between the effects of food on the pharmacokinetics of oral antineoplastic drugs and their physicochemical properties
Drug–Drug Interactions with Direct Oral Anticoagulants
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes
Theoretical rejection of fifty-four antineoplastic drugs by different nanofiltration membranes
From therapeutic drug monitoring to total drug monitoring and drug-omics
Improvement of oral antineoplastic therapy by means of pharmacometric approaches & therapeutic drug monitoring
Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review
Developing a nationwide infrastructure for therapeutic drug monitoring of targeted oral anticancer drugs: the ON-TARGET study protocol
Targeted drug delivery
Beyond Nanoparticle‐Based Intracellular Drug Delivery: Cytosol/Organelle‐Targeted Drug Release and Therapeutic Synergism
Optimization of beta-lactam dosing through targeted therapeutic drug monitoring
Riboflavin-Targeted Drug Delivery
Relationship between the effects of food on the pharmacokinetics of oral antineoplastic drugs and their physicochemical properties
Drug–Drug Interactions with Direct Oral Anticoagulants
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes
Theoretical rejection of fifty-four antineoplastic drugs by different nanofiltration membranes
From therapeutic drug monitoring to total drug monitoring and drug-omics
Improvement of oral antineoplastic therapy by means of pharmacometric approaches & therapeutic drug monitoring
Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review
Developing a nationwide infrastructure for therapeutic drug monitoring of targeted oral anticancer drugs: the ON-TARGET study protocol
Targeted drug delivery
Beyond Nanoparticle‐Based Intracellular Drug Delivery: Cytosol/Organelle‐Targeted Drug Release and Therapeutic Synergism
Optimization of beta-lactam dosing through targeted therapeutic drug monitoring
Riboflavin-Targeted Drug Delivery
Relationship between the effects of food on the pharmacokinetics of oral antineoplastic drugs and their physicochemical properties
Drug–Drug Interactions with Direct Oral Anticoagulants
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes
Theoretical rejection of fifty-four antineoplastic drugs by different nanofiltration membranes